{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:48:03Z","timestamp":1789534083183,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xkme.2025.101197","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:18:00Z","timestamp":1765037880000},"page":"101197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Incidence and Risk Factors of Gout in Non-dialysis Chronic Kidney Disease Patients With Asymptomatic Hyperuricemia"],"prefix":"10.1016","volume":"8","author":[{"given":"Ilia","family":"Beberashvili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza Abu","family":"Marsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Doenyas-Barak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Maslakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shai","family":"Efrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.xkme.2025.101197_bib1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.xkme.2025.101197_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta-analysis","volume":"63","author":"Grayson","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.xkme.2025.101197_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056864","article-title":"High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies","volume":"8","author":"Lv","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.xkme.2025.101197_bib4","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1210\/jc.2015-2527","article-title":"Serum uric acid levels and risk of metabolic syndrome: a dose-response meta-analysis of prospective studies","volume":"100","author":"Yuan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.xkme.2025.101197_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30267-2","article-title":"Increased serum uric acid over five years is a risk factor for developing fatty liver","volume":"8","author":"Jensen","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.xkme.2025.101197_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100801","article-title":"Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xkme.2025.101197_bib7","article-title":"Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.xkme.2025.101197_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/ndt\/gft378","article-title":"Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis","volume":"29","author":"Bose","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.xkme.2025.101197_bib9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ajkd.2012.07.021","article-title":"Uric acid as a target of therapy in CKD","volume":"61","author":"Jalal","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.xkme.2025.101197_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ekir.2022.11.016","article-title":"Uric acid and chronic kidney disease: still more to do","volume":"8","author":"Johnson","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.xkme.2025.101197_bib11","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","article-title":"Febuxostat Therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial","volume":"72","author":"Kimura","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.xkme.2025.101197_bib12","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1681\/ASN.2007111256","article-title":"Association of incident gout and mortality in dialysis patients","volume":"19","author":"Cohen","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2025.101197_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ndt\/gfu352","article-title":"Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study","volume":"30","author":"Jing","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2025.101197_bib14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1253\/circj.CJ-20-0406","article-title":"Uric acid as a risk factor for chronic kidney disease and cardiovascular disease\u2014Japanese guideline on the management of asymptomatic hyperuricemia","volume":"85","author":"Hisatome","year":"2021","journal-title":"Circ J"},{"issue":"5","key":"10.1016\/j.xkme.2025.101197_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"21","key":"10.1016\/j.xkme.2025.101197_bib16","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2165\/00003495-200464210-00003","article-title":"Management of acute and chronic gouty arthritis: present state-of-the-art","volume":"64","author":"Schlesinger","year":"2004","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.xkme.2025.101197_bib17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.xkme.2025.101197_bib18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.xkme.2025.101197_bib19","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: the Framingham Study risk score functions","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"issue":"11","key":"10.1016\/j.xkme.2025.101197_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050046","article-title":"Reduced glomerular function and prevalence of gout: NHANES 2009-10","volume":"7","author":"Krishnan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xkme.2025.101197_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2369-12-36","article-title":"Chronic kidney disease in gout in a managed care setting","volume":"12","author":"Fuldeore","year":"2011","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2025.101197_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006843","article-title":"Chronic kidney disease as a risk factor for incident gout among men and women: retrospective cohort study using data from the Framingham Heart Study","volume":"5","author":"Wang","year":"2015","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.xkme.2025.101197_bib23","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1002\/art.38171","article-title":"Chronic kidney disease and the risk of incident gout among middle-aged men: a seven-year prospective observational study","volume":"65","author":"Krishnan","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.xkme.2025.101197_bib24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2215\/CJN.06790616","article-title":"The 3-year incidence of gout in elderly patients with CKD","volume":"12","author":"Tan","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101197_bib25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/ndt\/15.5.644","article-title":"Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients?","volume":"15","author":"Schreiner","year":"2000","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.xkme.2025.101197_bib26","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1007\/s10067-022-06416-4","article-title":"Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study","volume":"41","author":"Uhlig","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101197_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.numecd.2010.07.012","article-title":"Purine-rich foods, protein intake, and the prevalence of hyperuricemia: the Shanghai Men\u2019s Health Study","volume":"22","author":"Villegas","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.xkme.2025.101197_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260242","article-title":"The dietary intake of chronic kidney disease according to stages: findings from the Korean National Health and Nutritional Examination Survey","volume":"16","author":"Kim","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.xkme.2025.101197_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.xkme.2025.101197_bib30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archinte.1987.00370040027005","article-title":"Is thiazide-produced uric acid elevation harmful? Analysis of data from the hypertension detection and follow-up program","volume":"147","author":"Langford","year":"1987","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.xkme.2025.101197_bib31","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3949\/ccjm.69.8.594","article-title":"Asymptomatic hyperuricemia: to treat or not to treat","volume":"69","author":"Dincer","year":"2002","journal-title":"Cleve Clin J Med"},{"issue":"3S","key":"10.1016\/j.xkme.2025.101197_bib32","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.semarthrit.2020.04.008","article-title":"Gout epidemiology and comorbidities","volume":"50","author":"Singh","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.xkme.2025.101197_bib33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archinte.165.7.742","article-title":"Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study","volume":"165","author":"Choi","year":"2005","journal-title":"Arch Intern Med"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952500233X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952500233X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:31:36Z","timestamp":1770366696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259005952500233X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S259005952500233X"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101197","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Incidence and Risk Factors of Gout in Non-dialysis Chronic Kidney Disease Patients With Asymptomatic Hyperuricemia","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101197"}}